Effects of collimator dependency and correction methods on I-123 SPECT images using x-ray-based attenuation map

Low energy (LE) collimator is generally used in I-123 SPECT imaging. However, the septal penetration and scattering of photons emitted with energy above 159 keV will affect the image contrast and quantitative accuracy of images. To reduce this effect, medium energy (ME) collimator has been used with the cost of lower counting statistics and spatial resolution. The effects of collimator dependency on the quantitative accuracy of attenuation corrected (AC) I-123 SPECT images using X-ray-based attenuation map was investigated. Both brain and heart/thorax phantoms were used to evaluate different degree of attenuation effect between brain and thorax. Experiments were performed at different target-to-background ratios to simulate different object contrast. Both photopeak and scatter projections were collected for dual-energy window scatter correction (SC). Images were reconstructed and compared using different reconstruction methods, which included FBP (filtered backprojection), and OSEM (ordered subset expectation maximization) without corrections, with AC, with SC, and with AC and SC. In both phantom studies, the image contrast and quantitative accuracy were both improved with the use of CT-based transmission map for AC. The image contrast provided by ME collimator was better than that of LE collimator, especially in the region with void activity of thorax phantom. From the results of phantom studies, medium energy collimator with CT-based transmission map showed improvements in image contrast and quantitative accuracy of I-123 SPECT images.

[1]  S. Liggett,et al.  Activity of the uptake-1 norepinephrine transporter as measured by I-123 MIBG in heart failure patients with a loss-of-function polymorphism of the presynaptic α2C-adrenergic receptor , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[2]  R. Jaszczak,et al.  Improved SPECT quantification using compensation for scattered photons. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  E C Frey,et al.  Quantitative single-photon emission computed tomography: basics and clinical considerations. , 1994, Seminars in nuclear medicine.

[4]  Jan Booij,et al.  The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism , 2001, European Journal of Nuclear Medicine.

[5]  Brad Kemp,et al.  A multicenter evaluation of commercial attenuation compensation techniques in cardiac SPECT using phantom models. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[6]  I G Zubal,et al.  Significance of nonuniform attenuation correction in quantitative brain SPECT imaging. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  Yusuke Inoue,et al.  Collimator choice in cardiac SPECT with I-123-labeled tracers , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[8]  Philippe R. Franken,et al.  Influence of high-energy photons on the spectrum of iodine-123 with low- and medium-energy collimators: consequences for imaging with 123I-labelled compounds in clinical practice , 1999, European Journal of Nuclear Medicine.

[9]  Irène Buvat,et al.  Quantitative accuracy of dopaminergic neurotransmission imaging with (123)I SPECT. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  Andrea Varrone,et al.  Contribution of scatter and attenuation compensation to SPECT images of nonuniformly distributed brain activities. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  Brian F. Hutton Cardiac single-photon emission tomography: Is attenuation correction enough? , 2004, European Journal of Nuclear Medicine.

[12]  M P Sandler,et al.  Image fusion using an integrated, dual-head coincidence camera with X-ray tube-based attenuation maps. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  A Pupi,et al.  European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) receptor ligands. , 2002, European journal of nuclear medicine and molecular imaging.

[14]  K. Ohtomo,et al.  Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[15]  Pierre Grangeat,et al.  Absolute quantitation of iodine-123 epidepride kinetics using single-photon emission tomography: comparison with carbon-11 epidepride and positron emission tomography , 1999, European Journal of Nuclear Medicine.

[16]  B. van Eck-Smit,et al.  Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: a phantom study , 2005, European Journal of Nuclear Medicine and Molecular Imaging.